Allmed Competitors

002950 Stock

9.00 0.01 0.11%

Allmed Medical Products competes with Shanghai Sanyou, Ningxia Younglight, Zhejiang Yongjin, Anhui Transport, and Yingde Greatchem; as well as few others. The company operates under Health Care Equipment & Supplies sector and is part of Health Care industry. Analyzing Allmed Medical competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Allmed Medical to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Allmed Medical Correlation with its peers.

You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Allmed Medical competition on your existing holdings.

Specify up to 10 symbols:

Hype

Prediction

Low	Estimated	High
5.77	9.00	12.23

Details

Intrinsic

Valuation

Low	Real	High
4.06	7.29	10.52

Details

Naive

Forecast

Low	Next	High
5.95	9.18	12.41

Details

Bollinger

Band Projection (param)

Lower	Middle Band	Upper
8.31	9.17	10.02

Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Allmed Medical. Your research has to be compared to or analyzed against Allmed Medical's peers to derive any actionable benefits. When done correctly, Allmed Medical's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Allmed Medical Products.

Allmed Medical Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Allmed Medical and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Allmed and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Allmed Medical Products does not affect the price movement of the other competitor.

	688085	000635	603995	603357	300804	603122	300848	002173
688085		0.89	0.88	0.92	0.94	0.92	0.88	0.88	688085
000635	0.89		0.75	0.86	0.87	0.94	0.96	0.98	000635
603995	0.88	0.75		0.94	0.93	0.84	0.79	0.78	603995
603357	0.92	0.86	0.94		0.98	0.91	0.91	0.88	603357
300804	0.94	0.87	0.93	0.98		0.93	0.91	0.88	300804
603122	0.92	0.94	0.84	0.91	0.93		0.93	0.95	603122
300848	0.88	0.96	0.79	0.91	0.91	0.93		0.96	300848
002173	0.88	0.98	0.78	0.88	0.88	0.95	0.96		002173
	688085	000635	603995	603357	300804	603122	300848	002173

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Risk-Adjusted Indicators

There is a big difference between Allmed Stock performing well and Allmed Medical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Allmed Medical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
688085	2.52	0.39	0.08	(6.31)	2.71	(3.04)	5.86	(4.09)	28.94
000635	2.39	0.68	0.14	(1.08)	2.67	(2.72)	7.69	(4.58)	17.40
603995	1.78	0.29	0.06	(2.25)	2.16	(2.04)	5.07	(3.76)	18.05
603357	1.85	0.36	0.08	(27.37)	2.26	(1.87)	4.07	(3.06)	16.77
300804	1.94	0.34	0.05	(0.91)	2.79	(2.13)	3.53	(3.15)	24.12
603122	3.09	0.41	0.06	(1.55)	3.86	(3.13)	9.98	(6.38)	20.07
300848	2.90	0.56	0.09	(0.96)	3.44	(3.37)	7.91	(4.45)	26.85
002173	2.96	0.64	0.12	6.32	3.83	(3.02)	6.93	(6.37)	19.23

Cross Equities Net Income Analysis

Compare Allmed Medical Products and related stocks such as Shanghai Sanyou Medical, Ningxia Younglight, and Zhejiang Yongjin Metal Net Income Over Time

	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
688085	3.1 M	3.1 M	3.1 M	3.1 M	3.1 M	3.1 M	3.1 M	5.2 M	62.1 M	97.8 M	118.6 M	186.4 M	190.8 M	95.6 M	104.4 M
000635	28.8 M	104.4 M	30.4 M	77 M	52.3 M	29.7 M	109.8 M	93.3 M	26.8 M	51.1 M	69.6 M	4.3 M	(388.9 M)	(667.8 M)	(634.4 M)
603995	245.9 M	245.9 M	245.9 M	245.9 M	245.9 M	245.9 M	245.9 M	217.1 M	331.2 M	332.8 M	414.4 M	591.1 M	486.6 M	453 M	422.4 M
603357	195.8 M	195.8 M	195.8 M	195.8 M	195.8 M	195.8 M	195.8 M	288.8 M	436.8 M	324.8 M	363.2 M	388.3 M	442.8 M	488.3 M	402.7 M
603122	67.1 M	67.1 M	67.1 M	67.1 M	67.1 M	67.1 M	67.1 M	67.1 M	67.1 M	67.1 M	72.6 M	80.2 M	82.7 M	47.2 M	56 M
300848	27.2 M	27.2 M	27.2 M	27.2 M	27.2 M	27.2 M	27.2 M	44.4 M	55.4 M	83.4 M	102 M	119.1 M	111.3 M	87.9 M	86.7 M
002173	17.2 M	30 M	38.2 M	23.7 M	(65.3 M)	(65.3 M)	114.7 M	140.7 M	29.7 M	(1.1 B)	(314.5 M)	(105.2 M)	(73.7 M)	(34.3 M)	(36 M)

Allmed Medical Products and related stocks such as Shanghai Sanyou Medical, Ningxia Younglight, and Zhejiang Yongjin Metal Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Allmed Medical Products financial statement analysis. It represents the amount of money remaining after all of Allmed Medical Products operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Allmed Medical Competitive Analysis

The better you understand Allmed Medical competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Allmed Medical's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Allmed Medical's competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	002950	688085	000635	603995	603357	300804	603122	300848	002173
	0.11 9.00 Allmed	3.39 21.06 Shanghai	0.24 8.43 Ningxia	1.11 19.19 Zhejiang	1.13 9.83 Anhui	1.15 25.45 Yingde	0.53 7.54 Cowealth	0.38 18.63 Miracll	2.07 8.89 Innovative
Market Volatility (90 Days Market Risk)	Slightly risky	Somewhat reliable	Slightly risky	Not too volatile	Somewhat reliable	Not too volatile	Slightly risky	Somewhat reliable	Slightly risky
Market Performance (90 Days Performance)	OK	OK	Good	OK	Good	OK	Good	Good	Good
Odds of Financial Distress (Probability Of Bankruptcy)	Very Small	Low	About Average	Low	Low	Low	Very Small	Very Small	Low
Current Valuation (Equity Enterprise Value)	Over Valued	Over Valued	Over Valued	Over Valued	Over Valued	Over Valued	Over Valued	Over Valued	Over Valued
Buy or Sell Advice (Average Analysts Consensus)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available
Trade Advice (90 Days Macroaxis Advice)	Strong Sell	Strong Sell	Strong Sell	Strong Sell	Strong Sell	Strong Sell	Strong Sell	Strong Sell	Strong Sell
Net Asset	5.08 B	2.26 B	2.68 B	12.58 B	6.51 B	N/A	1.46 B	3.35 B	2.28 B
Profit Margin	0.0706	0.0872	-0.24	0.0167	0.12	0.0503	0.0306	0.0434	-0.0592
EBITDA	518.43 M	67.9 M	(380.49 M)	1.65 B	538.93 M	79.42 M	45.11 M	69.81 M	33.94 M
Operating Margin	0.11	0.22	-0.23	0.0301	0.25	0.11	0.0433	0.0568	-0.0793
Current Valuation	5.84 B	4.7 B	3.16 B	9.61 B	5.26 B	1.66 B	2.92 B	8.39 B	3.44 B
Price To Book	1.71	2.74	1.9	1.27	1.54	1.44	2.57	5.97	2.13
Retained Earnings	1.72 B	581.46 M	(701.36 M)	2.42 B	1.9 B	N/A	131.1 M	471.76 M	(1.3 B)
Beta	0.34	-0.24	0.74	0.98	0.28	N/A	0.54	0.45	0.64
Number Of Employees	4.68 K	466	1.9 K	3.37 K	2.24 K	819	240	564	N/A
Shares Outstanding	633.27 M	248.45 M	303.49 M	365.62 M	560.78 M	74 M	398.05 M	414.19 M	441.28 M
Cash Flow From Operations	423.5 M	267.43 M	(596.37 M)	906.06 M	273.32 M	N/A	11.28 M	230.23 M	11.03 M
Annual Yield	0.003	N/A	N/A	N/A	N/A	N/A	0.008	0.0054	N/A
Total Debt	749.57 M	4.15 M	1.08 B	998.12 M	300.2 M	N/A	53.92 M	709.13 M	30.17 M
Return On Equity	0.0682	0.0232	-0.29	0.15	0.13	0.0272	0.026	0.0445	-0.0256
Return On Asset	0.0333	0.0103	-0.12	0.0523	0.0513	0.0107	0.016	0.0074	-0.0147
Book Value Per Share	5.37	7.69	4.44	15.08	6.37	17.72	2.93	3.12	4.18
Total Asset	5.08 B	2.26 B	2.68 B	12.58 B	6.51 B	N/A	1.46 B	3.35 B	2.28 B
Last Dividend Paid	0.027	0.078	N/A	0.5	0.35	N/A	0.06	0.077	N/A
Target Price	N/A	N/A	25.0	N/A	27.0	26.62	N/A	15.0	N/A
Shares Owned By Institutions	0.85	14.52	0.45	12.46	2.24	3.29	0.29	2.9	1.64
Market Capitalization	5.7 B	5.23 B	2.56 B	7.02 B	5.51 B	1.88 B	3 B	7.72 B	3.92 B
Price To Sales	1.79	12.05	1.36	0.16	1.51	3.64	3.09	4.85	4.85
Net Income	110.4 M	91.22 M	(667.77 M)	453.01 M	488.29 M	N/A	47.19 M	87.86 M	(34.29 M)
Earnings Per Share	0.36	0.14	-1.47	1.7	0.78	0.51	0.08	0.16	-0.11
Shares Owned By Insiders	64.94	51.57	54.0	49.33	50.74	74.98	57.6	76.2	42.32
Revenue	2.76 B	460.39 M	1.75 B	39.87 B	3.39 B	516.91 M	1.09 B	1.48 B	805.59 M
Working Capital	454.08 M	751.85 M	(418.66 M)	179.45 M	2.27 B	N/A	969.07 M	510.53 M	407.63 M
Gross Profit	872.17 M	577.77 M	(139.89 M)	1.79 B	777.66 M	N/A	257.56 M	200.3 M	46.16 M
Day Typical Price	9.0	20.85	8.36	19.18	9.77	25.38	7.53	18.6	8.8
Accumulation Distribution	0.0403	0.0415	0.0308	0.0273	0.0254	0.0326	0.0442	0.0549	0.0556
Market Facilitation Index	0.37	0.88	0.26	0.53	0.25	0.84	0.34	1.05	0.5
Daily Balance Of Power	0.027	0.7841	0.0769	0.3962	0.44	0.3452	0.1176	0.0667	0.36
Period Momentum Indicator	0.01	0.69	0.02	0.21	0.11	0.29	0.04	0.07	0.18
Rate Of Daily Change	1.0	1.03	1.0	1.01	1.01	1.01	1.01	1.0	1.02
Day Median Price	9.0	20.74	8.32	19.18	9.74	25.35	7.52	18.59	8.75
Price Action Indicator	N/A	0.66	0.12	0.12	0.15	0.24	0.04	0.08	0.23
Relative Strength Index	66.37	65.88	77.03	61.77	60.84	62.62	77.78	72.31	77.42
Coefficient Of Variation	617.31	958.77	560.7	927.56	685.39	959.36	1082.46	842.07	612.19
Mean Deviation	2.31	2.52	2.39	1.78	1.85	1.94	3.09	2.9	2.96
Jensen Alpha	0.5451	0.3914	0.681	0.2865	0.363	0.3417	0.4094	0.5631	0.6375
Total Risk Alpha	(0.03)	(0.25)	0.0296	(0.16)	(0.06)	(0.20)	(0.32)	(0.22)	(0.02)
Sortino Ratio	0.132	0.0832	0.1424	0.0582	0.0847	0.0547	0.0586	0.0946	0.1172
Downside Variance	9.1	9.46	11.41	6.09	7.61	9.89	18.28	15.26	19.92
Standard Deviation	3.31	3.77	3.47	2.61	2.55	2.97	4.2	4.27	4.04
Kurtosis	2.24	6.15	2.0	3.67	2.43	7.58	0.5084	4.53	0.6798
Potential Upside	6.54	5.86	7.69	5.07	4.07	3.53	9.98	7.91	6.93
Treynor Ratio	(3.49)	(6.31)	(1.08)	(2.25)	(27.37)	(0.91)	(1.55)	(0.96)	6.32
Maximum Drawdown	19.86	28.94	17.4	18.05	16.77	24.12	20.07	26.85	19.23
Variance	10.94	14.24	12.04	6.8	6.48	8.83	17.67	18.24	16.36
Market Risk Adjusted Performance	(3.48)	(6.30)	(1.07)	(2.24)	(27.36)	(0.90)	(1.54)	(0.95)	6.33
Risk Adjusted Performance	0.1315	0.0877	0.1441	0.0895	0.1185	0.0871	0.0788	0.099	0.133
Skewness	0.4196	0.9611	0.417	(0.11)	(0.12)	(0.47)	0.1714	0.1407	(0.29)
Semi Deviation	2.5	2.71	2.67	2.16	2.26	2.79	3.86	3.44	3.83
Information Ratio	0.1204	0.0678	0.1387	0.055	0.0918	0.0579	0.0596	0.0865	0.1293
Value At Risk	(4.61)	(4.09)	(4.58)	(3.76)	(3.06)	(3.15)	(6.38)	(4.45)	(6.37)
Expected Short fall	(2.68)	(3.04)	(2.72)	(2.04)	(1.87)	(2.13)	(3.13)	(3.37)	(3.02)
Downside Deviation	3.02	3.08	3.38	2.47	2.76	3.15	4.28	3.91	4.46
Semi Variance	6.23	7.36	7.12	4.65	5.1	7.78	14.93	11.87	14.64

Allmed Medical Competition Performance Charts

Five steps to successful analysis of Allmed Medical Competition

Allmed Medical's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Allmed Medical Products in relation to its competition. Allmed Medical's competition analysis typically involves several steps, including:

Identifying the key players in the market: This involves identifying the major competitors of Allmed Medical in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Allmed Medical's competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Allmed Medical Products, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Allmed Medical position

In addition to having Allmed Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run World Allocation Funds Thematic Idea Now

World Allocation Funds

Funds or Etfs investing in stocks, bonds, and cash of domestic markets as well as in markets of Canada, Japan, and Europe. The World Allocation Funds theme has 43 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize World Allocation Funds Theme or any other thematic opportunities.

View All Next

Launch

Other Information on Investing in Allmed Stock

Allmed Medical financial ratios help investors to determine whether Allmed Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Allmed with respect to the benefits of owning Allmed Medical security.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Allmed Competitors

Specify up to 10 symbols:

Allmed Medical Competition Correlation Matrix

Risk-Adjusted Indicators

Cross Equities Net Income Analysis

Allmed Medical Products and related stocks such as Shanghai Sanyou Medical, Ningxia Younglight, and Zhejiang Yongjin Metal Net Income description

Allmed Medical Competitive Analysis

Allmed Medical Competition Performance Charts

Five steps to successful analysis of Allmed Medical Competition

Complement your Allmed Medical position

Did You Try This Idea?

Run World Allocation Funds Thematic Idea Now

World Allocation Funds

Other Information on Investing in Allmed Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY